These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Three types of stereospecificity and the kinetic deuterium isotope effect in the oxidative deamination of dopamine as catalyzed by different amine oxidases. Yu PH. Biochem Cell Biol; 1988 Aug; 66(8):853-61. PubMed ID: 3143375 [Abstract] [Full Text] [Related]
4. Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues. Yu PH, Bailey BA, Durden DA, Boulton AA. Biochem Pharmacol; 1986 Mar 15; 35(6):1027-36. PubMed ID: 3954792 [Abstract] [Full Text] [Related]
5. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S. Chem Biol Interact; 2019 May 01; 304():139-147. PubMed ID: 30857888 [Abstract] [Full Text] [Related]
6. Does isatin interact with rat brain monoamine oxidases in vivo? Panova NG, Zemskova MA, Axenova LN, Medvedev AE. Neurosci Lett; 1997 Sep 12; 233(1):58-60. PubMed ID: 9324239 [Abstract] [Full Text] [Related]
8. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain. Clow A, Glover V, Oxenkrug GF, Sandler M. Neurosci Lett; 1989 Dec 15; 107(1-3):331-4. PubMed ID: 2616044 [Abstract] [Full Text] [Related]
9. Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Dyck LE, Durden DA, Yu PH, Davis BA, Boulton AA. Biochem Pharmacol; 1983 May 01; 32(9):1519-22. PubMed ID: 6860370 [Abstract] [Full Text] [Related]
10. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase. Andree TH, Clarke DE. Biochem Pharmacol; 1982 Mar 01; 31(5):825-30. PubMed ID: 7082351 [Abstract] [Full Text] [Related]
14. Enzymatic N-methylation of phenelzine catalyzed by methyltransferases from adrenal and other tissues. Yu PH, Davis BA, Durden DA. Drug Metab Dispos; 1991 Mar 01; 19(4):830-4. PubMed ID: 1680662 [Abstract] [Full Text] [Related]
19. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R, Olmos G, García-Sevilla JA. Br J Pharmacol; 1995 Feb 01; 114(4):837-45. PubMed ID: 7773544 [Abstract] [Full Text] [Related]
20. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat. Coutts RT, Mozayani A, Danielson TJ, Baker GB. J Pharm Sci; 1991 Aug 01; 80(8):765-7. PubMed ID: 1791538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]